Position in REGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$433,360
-$306,829 QoQ
Shares Held
695
-27.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#841
of 1,322 holders
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cooper Financial Group holds $3,046,656 across 2 Biotechnology names. REGN ranks #2 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,261 | $2,613,296 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
695 | $433,360 |
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $433,360 | 695 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $740,189 | 958 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $766,466 | 993 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $584,760 | 1,040 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $591,675 | 1,127 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $480,746 | 758 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $379,671 | 533 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $629,692 | 599 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $293,237 | 279 | Shares | Sole | 2024-07-15 | |
| 2022-03-31 | $386,226 | 553 | Shares | Sole | 2022-04-25 | |
| No filing history on record for this holder in this stock. | ||||||